These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


230 related items for PubMed ID: 14557343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul 07; 147(27-28):44. PubMed ID: 16041942
    [No Abstract] [Full Text] [Related]

  • 4. Pfizer launches Inspra for heart failure.
    Cardiovasc J S Afr; 2006 Jul 07; 17(4):220. PubMed ID: 17001435
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies.
    Pitt B.
    Mol Cell Endocrinol; 2004 Mar 31; 217(1-2):53-8. PubMed ID: 15134801
    [Abstract] [Full Text] [Related]

  • 7. Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?
    Pitt B.
    J Card Fail; 2002 Dec 31; 8(6 Suppl):S491-3. PubMed ID: 12555163
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adherence to aldosterone-blocking agents in patients with heart failure.
    Margolis J, Gerber RA, Roberts C, Gheorghiade M.
    Am J Ther; 2010 Dec 31; 17(5):446-54. PubMed ID: 20844344
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The EMPHASIS-HF study].
    Boccanelli A, Agostoni P.
    G Ital Cardiol (Rome); 2011 May 31; 12(5):315-8. PubMed ID: 21593949
    [No Abstract] [Full Text] [Related]

  • 12. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
    Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators.
    N Engl J Med; 2003 Apr 03; 348(14):1309-21. PubMed ID: 12668699
    [Abstract] [Full Text] [Related]

  • 13. [Aldosterone receptor antagonists in heart failure. Rightly brought back from retirement].
    Kolloch R, Offers E.
    MMW Fortschr Med; 2003 Nov 20; 145(47):42-4, 47. PubMed ID: 14725033
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Blocking aldosterone in heart failure.
    Shafiq MM, Miller AB.
    Ther Adv Cardiovasc Dis; 2009 Oct 20; 3(5):379-85. PubMed ID: 19661156
    [Abstract] [Full Text] [Related]

  • 17. Management of heart failure and left ventricular systolic dysfunction following acute myocardial infarction.
    Conti CR.
    Clin Cardiol; 2005 Jan 20; 28(1):1-2. PubMed ID: 15704523
    [No Abstract] [Full Text] [Related]

  • 18. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.
    Aaronson K.
    Health News; 2003 May 20; 9(5):4. PubMed ID: 12739453
    [No Abstract] [Full Text] [Related]

  • 19. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
    Ajani AE, Marwick TH, Krum H.
    Cardiovasc Revasc Med; 2006 May 20; 7(4):234-6. PubMed ID: 17174870
    [Abstract] [Full Text] [Related]

  • 20. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction.
    Gheorghiade M, Khan S, Blair JE, Harinstein ME, Krum H, Mukherjee R, Pitt B, Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival (EPHESUS) Investigators.
    Am Heart J; 2009 Sep 20; 158(3):437-43. PubMed ID: 19699868
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.